Pages that link to "Q51877467"
Jump to navigation
Jump to search
The following pages link to Web-based design and evaluation of T-cell vaccine candidates. (Q51877467):
Displayed 28 items.
- Can immunotherapy be useful as a "functional cure" for infection with Human Immunodeficiency Virus-1? (Q26865388) (← links)
- A global approach to HIV-1 vaccine development (Q27024614) (← links)
- New concepts in HIV-1 vaccine development (Q28067027) (← links)
- Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials (Q28394899) (← links)
- The Number and Complexity of Pure and Recombinant HIV-1 Strains Observed within Incident Infections during the HIV and Malaria Cohort Study Conducted in Kericho, Kenya, from 2003 to 2006 (Q28608652) (← links)
- Defining epitope coverage requirements for T cell-based HIV vaccines: theoretical considerations and practical applications (Q30410411) (← links)
- Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys (Q33712578) (← links)
- Design and utilization of epitope-based databases and predictive tools (Q33746654) (← links)
- Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge (Q33804531) (← links)
- Short conserved sequences of HIV-1 are highly immunogenic and shift immunodominance (Q34991038) (← links)
- Quantification of the epitope diversity of HIV-1-specific binding antibodies by peptide microarrays for global HIV-1 vaccine development (Q35072515) (← links)
- Nedd4-mediated increase in HIV-1 Gag and Env proteins and immunity following DNA-vaccination of BALB/c mice (Q35116068) (← links)
- Evaluating potential T-cell epitope peptides for detecting HIV-specific T cell responses in a highly diverse HIV-1 epidemic from Cameroon (Q35218117) (← links)
- Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost (Q35760486) (← links)
- Attenuation of Replication-Competent Adenovirus Serotype 26 Vaccines by Vectorization (Q36211653) (← links)
- Breadth of cellular and humoral immune responses elicited in rhesus monkeys by multi-valent mosaic and consensus immunogens (Q36638450) (← links)
- Expanded breadth of the T-cell response to mosaic human immunodeficiency virus type 1 envelope DNA vaccination (Q37099729) (← links)
- T-cell vaccine strategies for human immunodeficiency virus, the virus with a thousand faces (Q37333743) (← links)
- Novel in silico tools for designing peptide-based subunit vaccines and immunotherapeutics (Q38789472) (← links)
- Polyvalent vaccine approaches to combat HIV-1 diversity (Q39108740) (← links)
- A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial (Q40485544) (← links)
- Protection of bats (Eptesicus fuscus) against rabies following topical or oronasal exposure to a recombinant raccoon poxvirus vaccine (Q41924718) (← links)
- OptiTope--a web server for the selection of an optimal set of peptides for epitope-based vaccines. (Q41981083) (← links)
- Computational Design of Epitope-Enriched HIV-1 Gag Antigens with Preserved Structure and Function for Induction of Broad CD8 T Cell Responses (Q59355929) (← links)
- A PRRSV GP5-Mosaic vaccine: Protection of pigs from challenge and ex vivo detection of IFNγ responses against several genotype 2 strains (Q61805548) (← links)
- Broad Protection of Pigs against Heterologous PRRSV Strains by a GP5-Mosaic DNA Vaccine Prime/GP5-Mosaic rVaccinia (VACV) Vaccine Boost (Q89977102) (← links)
- T cell-based strategies for HIV-1 vaccines (Q90479100) (← links)
- Dengue Mosaic Vaccines Enhance Cellular Immunity and Expand the Breadth of Neutralizing Antibody Against All Four Serotypes of Dengue Viruses in Mice (Q91688064) (← links)